GlassScriptPhysician profile
Peter W Mortensen
NPI 1376907840
$2,424.93
in general payments reported to CMS, 2019-2025
16 companies · $40.10 in 2025
The $40.10 reported for 2025 was less than what a typical Neuro-Ophthalmology provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.64 · 2022: $302 · 2023: $879 · 2024: $1,115 · 2025: $40.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,033.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $549.58 | 2022-2024 | Soliris, Ultomiris |
| Sun Pharmaceutical Industries INC. | $407.82 | 2022-2024 | Cequa |
| Horizon Therapeutics Plc | $359.28 | 2023 | Uplizna, Tepezza |
| Amgen INC. | $350.34 | 2024 | Uplizna, Tepezza |
| Bausch & Lomb Americas INC. | $167.77 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Abbvie INC. | $105.04 | 2022-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $89.64 | 2021 | |
| Oyster Point Pharma, INC. | $86.81 | 2022-2024 | Tyrvaya, Ryzumvi |
| Penumbra, INC. | $74.22 | 2024 | Penumbra Coil 400 |
| Dompe US, INC. | $53.32 | 2024 | Oxervate |
| Ucb, INC. | $39.59 | 2024 | Rystiggo |
| Biotissue Holdings INC. | $36.51 | 2022 | |
| Apellis Pharmaceuticals, INC. | $34.44 | 2022-2023 | |
| Astellas Pharma US INC | $34.23 | 2023 | |
| Genentech USA, INC. | $22.71 | 2024 | Vabysmo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $13.63 | 2024 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mortensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.